Upon knockdown of CD44, the glycoprotein carcinoembryonic antigen (CEA) acts as a compensatory mechanism to mediate colon cancer cell interactions with E‐selectin (Thomas et al, 2008). This evidence concerns the gene CEACAM5 and malignant colon neoplasm.